Business Description
Emergent BioSolutions Inc
NAICS : 325412
SIC : 2834
Description
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.46 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 1.02 | |||||
| Debt-to-EBITDA | -34.2 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.62 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2 | |||||
| 3-Year Book Growth Rate | 9.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.31 | |||||
| 9-Day RSI | 23.97 | |||||
| 14-Day RSI | 27.33 | |||||
| 6-1 Month Momentum % | -34.28 | |||||
| 12-1 Month Momentum % | -68.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.98 | |||||
| Quick Ratio | 0.7 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 218.37 | |||||
| Days Sales Outstanding | 44.35 | |||||
| Days Payable | 57.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.11 | |||||
| Operating Margin % | -14.81 | |||||
| Net Margin % | -19.97 | |||||
| ROE % | -14.84 | |||||
| ROA % | -7.69 | |||||
| ROIC % | -6.86 | |||||
| ROC (Joel Greenblatt) % | -15.53 | |||||
| ROCE % | -7.59 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 5.08 | |||||
| PS Ratio | 0.36 | |||||
| PB Ratio | 0.29 | |||||
| Price-to-Tangible-Book | 0.93 | |||||
| EV-to-EBIT | -6.34 | |||||
| EV-to-EBITDA | -28.45 | |||||
| EV-to-Revenue | 1.04 | |||||
| EV-to-Forward-Revenue | 1.5 | |||||
| EV-to-FCF | -6.81 | |||||
| Price-to-Projected-FCF | 0.17 | |||||
| Price-to-Median-PS-Value | 0.13 | |||||
| Earnings Yield (Greenblatt) % | -15.77 | |||||
| Forward Rate of Return (Yacktman) % | 38.54 |
How Emergent BioSolutions Inc (EBS) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:EBS
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,120.9 | ||
| EPS (TTM) ($) | -4.48 | ||
| Beta | 0.85 | ||
| Volatility % | 55.24 | ||
| 14-Day RSI | 27.33 | ||
| 14-Day ATR ($) | 0.689792 | ||
| 20-Day SMA ($) | 10.0235 | ||
| 12-1 Month Momentum % | -68.25 | ||
| 52-Week Range ($) | 7.74 - 45.14 | ||
| Shares Outstanding (Mil) | 50.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Emergent BioSolutions Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Emergent BioSolutions Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Emergent BioSolutions Inc Frequently Asked Questions
What is Emergent BioSolutions Inc(EBS)'s stock price today?
The current price of EBS is $8.10. The 52 week high of EBS is $45.14 and 52 week low is $7.74.
When is next earnings date of Emergent BioSolutions Inc(EBS)?
The next earnings date of Emergent BioSolutions Inc(EBS) is 2023-04-28 Est..
Does Emergent BioSolutions Inc(EBS) pay dividends? If so, how much?
Emergent BioSolutions Inc(EBS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
